For instance, Hu et al. found that lncRNA GAPLINC is able to upregulate the expression level of CD44 by binding to miR‐311‐3p to weaken its inhibitory effect on CD44, thereby regulating the migration path and proliferation process of cells, which indicates that lncRNA GAPLINC acts as a molecular bait of miR‐311‐3p and a ceRNA of oncogene CD44 in GC.7 The gene discussed is CD44; the disease is gastric cancer.